When used as a solo therapy, solengepras (CVN424) — an oral treatment being developed by Cerevance — was seen…
Articles by Michela Luciano, PhD
Medications commonly used to treat conditions such as high blood pressure, high cholesterol, and pain may delay Parkinson’s disease…
A new positron emission tomography (PET) radiotracer can accurately visualize inflammation within the healthy human brain, a first-in-human study found.
Irlab Therapeutics is moving its oral candidate, IRL757, into a Phase 1b clinical study to assess its safety and…
The Michael J. Fox Foundation (MJFF) has brought together top experts from around the world to speed up research…
People who develop Parkinson’s disease begin turning more slowly while walking — often using wider turning arcs —  nearly…